Detalhe da pesquisa
1.
The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States.
Value Health
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636697
2.
Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
Pharm Stat
; 22(5): 903-920, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321565
3.
Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review.
Future Oncol
; 18(16): 2029-2039, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196866
4.
Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs.
Value Health
; 24(9): 1294-1301, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452709
5.
Comparing cure rates for gemtuzumab ozogamicin plus standard chemotherapy vs standard chemotherapy alone in acute myeloid leukemia patients.
Future Oncol
; 17(22): 2883-2892, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858190
6.
Extrapolating Survival Data Using Historical Trial-Based a Priori Distributions.
Value Health
; 22(9): 1012-1017, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511177
7.
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non-Small Cell Lung Cancer.
Value Health
; 21(1): 9-17, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29304946
8.
Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
Eur J Haematol
; 96(1): 46-54, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25779478
9.
Which factors enhance positive drug reimbursement recommendation in Scotland? A retrospective analysis 2006-2013.
Value Health
; 18(2): 284-91, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25773564
10.
Improved estimation of overall survival and progression-free survival for state transition modeling.
J Comp Eff Res
; 13(1): e230031, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099516
11.
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.
Leuk Lymphoma
; 65(4): 481-492, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345269
12.
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses.
Res Synth Methods
; 14(2): 211-233, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283960
13.
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity.
J Comp Eff Res
; 12(3): e220159, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651607
14.
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes.
Clin Lung Cancer
; 24(6): 483-497, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451931
15.
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer.
Pharmacoecon Open
; 7(3): 455-467, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811822
16.
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data.
J Comp Eff Res
; 11(7): 513-521, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315280
17.
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies.
Eur Heart J Qual Care Clin Outcomes
; 8(5): 529-538, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895806
18.
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 39(9): 4230-4249, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876974
19.
Novel and existing flexible survival methods for network meta-analyses.
J Comp Eff Res
; 2022 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093741
20.
Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden.
Scand J Infect Dis
; 43(4): 304-12, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21231811